Japan Tobacco (2914) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 May, 2026Executive summary
Q1 2026 delivered a strong start with consolidated revenue rising 15.2% year-over-year to JPY 924.0 billion, and operating profit up 24.7%, driven by robust tobacco business performance and RRP momentum, especially Ploom.
Adjusted operating profit (AOP) increased 22.8% year-over-year, with net profit up 27.3%, supported by improved financial income/expenses and reduced amortization costs.
The Pharmaceutical Business was classified as discontinued operations, with only continuing operations reflected in current results.
Positive FX impact, notably from the Russian ruble, contributed to profit growth.
The Middle East situation is being monitored, but no material operational impact has been observed.
Financial highlights
AOP at constant FX increased by 20.5% year-over-year, with core revenue at constant FX up 9.8% to JPY 842.5 billion.
Revenue and AOP in the tobacco business saw double-digit growth, driven by pricing and favorable phasing of promotional activities.
RRP volume surged 44.2% year-over-year, with Ploom showing strong momentum and RRP-related revenue up 37.3% for the 12-month period ending March 2026.
Processed food business revenue rose by JPY 1.4 billion year-over-year, offsetting higher raw material costs.
Gross profit for Q1 2026 was ¥544.96 billion, up from ¥462.40 billion in Q1 2025.
Outlook and guidance
Full-year guidance remains unchanged, with management confident in achieving targets barring major surprises.
FY2026 revenue is forecast at ¥3,697.0 billion (+6.6% YoY), operating profit at ¥921.0 billion (+6.2%), and profit attributable to owners at ¥570.0 billion (+11.7%).
Q2 and beyond expected to see increased investment, especially in RRP marketing, and possible deceleration in top-line and volume growth, already factored into guidance.
Adjusted operating profit at constant FX is expected to grow at a high single-digit annual average during the 2026–2028 business plan period.
Dividend payout ratio for FY2026 is set at 75.2%, with a forecast total dividend of ¥242 per share.
Latest events from Japan Tobacco
- Strong H1 2026 results and upgraded full-year outlook, led by tobacco and RRP growth.2914
Q2 2026 - Record-high profit and revenue in FY2025, with robust outlook and continued RRP expansion.2914
Q4 2025 - Record-high profit and revenue, higher guidance, and increased dividend after business divestiture.2914
Q3 2025 - Strong revenue and profit growth led to higher forecasts and dividend guidance for 2025.2914
Q2 2025 - Strong tobacco pricing and RRP growth drove higher profit and raised full-year guidance.2914
Q2 2024 - Revenue up 11% and US market share expanded via Vector, but profit faces cost and litigation risks.2914
Q3 2024 - Q1 2025 saw robust profit growth, pharma divestment to Shionogi, and steady dividend guidance.2914
Q1 2025 - Record revenue and profit growth in FY2024, with high single-digit AOP growth targeted for 2025.2914
Q4 2024